|
Dr. Parekh joined Phyton Biotech in 2005. He leads Phyton's Cell Culture Process development and Pilot Plant Operations. His expertise is in the use of plant, mammalian, and microbial cell culture technologies for the large scale production of biopharmaceuticals and cGMP fermentation processes. He received his Ph.D. in Industrial Fermentations Microbiology from the University Department of Chemical Technology, Bombay. Following several years at the University of Toronto (Chemical & Biochemical Engineering) and the University of Illinois (Food Engineering), Dr. Parekh was employed at Merck & Co., where he supervised an interdisciplinary team responsible for the development of early stage technology and its transfer to commercial manufacture. He was most recently employed at Dow Agrosciences as Global Technology Leader. At Dow, Dr. Parekh led the joint efforts between Eli Lilly and Dow for strain advancement and process optimization. More recently he was engaged in the use of plant cell culture technology for the production of transgenic proteins. Dr. Parekh is on the editorial board of Process Biochemistry International, and has edited three books on the industrial applications of cell culture-based processes. | 